Hypothesis / aims of study
Pelvic organ prolapse (POP) is a recognized complication following radical cystectomy (RC). However, there remains ongoing debate regarding its incidence and the optimal (surgical) management of post-RC POP. The aim of this systematic review was to provide a comprehensive overview of the available literature on the incidence and treatment options for POP in patients who have undergone radical cystectomy.
Study design, materials and methods
This systematic review was conducted in accordance with PRISMA guidelines [1]. Studies were included if they assessed the incidence or treatment options for POP in patients with radical pelvic surgery in which at least the bladder and other pelvic organs were removed, e.g. radical cystectomy and anterior exenteration. Studies exclusively reporting vaginal evisceration were excluded. Given the paucity of high-level evidence, all study designs were eligible, including case reports and case series. A systematic search of PubMed and Embase was conducted up to 22 October 2025 using the following search terms: ("Pelvic organ prolapse"[Mesh] OR prolaps*[tiab] OR POP[tiab] OR enterocele[tiab] OR rectocele[tiab] OR ("perineal"[tiab] AND "hernia*"[tiab]) OR "pelvic descent"[tiab] OR "vaginal dehiscence"[tiab]) AND ("cystectomy"[Mesh] OR "cystectom*"[tiab] OR Bricker[tiab] OR "Wallace"[tiab] OR studer[tiab] OR "cutaneous ureterostomy"[tiab] OR Nesbit[tiab] OR "ileal conduit"[tiab] OR "neobladder"[tiab] OR "pelvic exenteration"[mesh] OR "anterior exenteration"[tiab] OR "pelvic exenteration"[tiab] OR "pelvic resection"[tiab])Interpretation of results
23 studies (all case reports or case series) described surgical management techniques for post-RC POP, encompassing a total of 48 patients. The majority of patients (n = 39, 81%) were treated via a transvaginal approach, while 5 patients (10%) underwent laparoscopic procedures and 4 patients (8%) were treated via an open abdominal approach. Mesh was utilized in 16 patients (33%). The various surgical approaches are illustrated in Figure 1, demonstrating both vaginal and abdominal placement options. The median follow-up duration was 12 months (range 3–60 months). An overview of the surgical techniques is provided in Figure 1 and Table 1.